{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:37:50Z","timestamp":1773081470481,"version":"3.50.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08151-5","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:02:51Z","timestamp":1743984171000},"page":"3391-3403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impulse control and related behavioral disorders in Parkinson\u2019s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-3766","authenticated-orcid":false,"given":"Stefano","family":"Terruzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Urh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-3798","authenticated-orcid":false,"given":"Daniele","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-7617","authenticated-orcid":false,"given":"Mario","family":"Rosanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-4693","authenticated-orcid":false,"given":"Cecilia","family":"Perin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"8151_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10072-017-3154-8","volume":"39","author":"C Papagno","year":"2018","unstructured":"Papagno C, Trojano L (2018) Cognitive and behavioral disorders in Parkinson\u2019s disease: an update. I: cognitive impairments. Neurol Sci 39:215\u2013223. https:\/\/doi.org\/10.1007\/s10072-017-3154-8","journal-title":"Neurol Sci"},{"key":"8151_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10072-017-3155-7","volume":"39","author":"L Trojano","year":"2018","unstructured":"Trojano L, Papagno C (2018) Cognitive and behavioral disorders in Parkinson\u2019s disease: an update. II: behavioral disorders. Neurol Sci 39:53\u201361. https:\/\/doi.org\/10.1007\/s10072-017-3155-7","journal-title":"Neurol Sci"},{"key":"8151_CR3","doi-asserted-by":"publisher","first-page":"106359","DOI":"10.1016\/j.clinbiomech.2024.106359","volume":"120","author":"D Bonacina","year":"2024","unstructured":"Bonacina D, Tosatto D, Ugolini A, Rossi F, Corno I, Pellicciari L et al (2024) Spatiotemporal, kinematic and kinetic gait characteristics in Parkinson\u2019s disease compared to healthy individuals: A systematic review with meta-analysis. Clin Biomech (Bristol) 120:106359. https:\/\/doi.org\/10.1016\/j.clinbiomech.2024.106359","journal-title":"Clin Biomech (Bristol)"},{"key":"8151_CR4","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan W-L (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Exon Publications 3\u201326","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"8151_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450","journal-title":"Nat Rev Neurosci"},{"key":"8151_CR7","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/j.lanepe.2024.100870","volume":"39","author":"E Burchill","year":"2024","unstructured":"Burchill E, Watson CJ, Fanshawe JB, Badenoch JB, Rengasamy E, Ghanem DA et al (2024) The impact of psychiatric comorbidity on Parkinson\u2019s disease outcomes: a systematic review and meta-analysis. Lancet Reg Health Eur 39:100870. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100870","journal-title":"Lancet Reg Health Eur"},{"key":"8151_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.parkreldis.2021.02.023","volume":"85","author":"V Czernecki","year":"2021","unstructured":"Czernecki V, Benchetrit E, Houot M, Pineau F, Mangone G, Corvol J-C et al (2021) Social cognitive impairment in early Parkinson\u2019s disease: A novel mild impairment? Parkinsonism Relat Disord 85:117\u2013121","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR9","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s10072-023-06697-w","volume":"44","author":"S Terruzzi","year":"2023","unstructured":"Terruzzi S, Funghi G, Meli C, Barozzi N, Zappini F, Papagno C et al (2023) The FACE test: a new neuropsychological task to assess the recognition of complex mental States from faces. Neurol Sci 44:2339\u20132347. https:\/\/doi.org\/10.1007\/s10072-023-06697-w","journal-title":"Neurol Sci"},{"key":"8151_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano C, Barone P, Trojano L, Santangelo G (2020) Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: A meta-analysis. Mov Disord 35:45\u201354. https:\/\/doi.org\/10.1002\/mds.27902","journal-title":"Mov Disord"},{"key":"8151_CR11","doi-asserted-by":"publisher","first-page":"120077","DOI":"10.1016\/j.jns.2021.120077","volume":"432","author":"CS e Sousa","year":"2022","unstructured":"e Sousa CS, Alarc\u00e3o J, Martins IP, Ferreira JJ (2022) Frequency of dementia in Parkinson\u2019s disease: A systematic review and meta-analysis. J Neurol Sci 432:120077\u2013120077","journal-title":"J Neurol Sci"},{"key":"8151_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2017.01.026","volume":"374","author":"R Balestrino","year":"2017","unstructured":"Balestrino R, Martinez-Martin P (2017) Reprint of neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease. J Neurol Sci 374:3\u20138","journal-title":"J Neurol Sci"},{"key":"8151_CR13","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40520-020-01470-x","volume":"32","author":"M De Rui","year":"2020","unstructured":"De Rui M, Inelmen EM, Trevisan C, Pigozzo S, Manzato E, Sergi G (2020) Parkinson\u2019s disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res 32:1211\u20131218. https:\/\/doi.org\/10.1007\/s40520-020-01470-x","journal-title":"Aging Clin Exp Res"},{"key":"8151_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M (2006) Caregiver-burden in Parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 12:35\u201341","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s13311-020-00875-w","volume":"17","author":"D Weintraub","year":"2020","unstructured":"Weintraub D (2020) Management of psychiatric disorders in Parkinson\u2019s disease: neurotherapeutics-movement disorders therapeutics. Neurotherapeutics 17:1511\u20131524","journal-title":"Neurotherapeutics"},{"key":"8151_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mds.29700","volume":"39","author":"I Debove","year":"2024","unstructured":"Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC et al (2024) Management of impulse control and related disorders in Parkinson\u2019s disease: an expert consensus. Mov Disord 39:235\u2013248. https:\/\/doi.org\/10.1002\/mds.29700","journal-title":"Mov Disord"},{"key":"8151_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub D, Claassen DO (2017) Impulse control and related disorders in Parkinson\u2019s disease. Int Rev Neurobiol 133:679\u2013717. https:\/\/doi.org\/10.1016\/bs.irn.2017.04.006","journal-title":"Int Rev Neurobiol"},{"key":"8151_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Mov Disord 30:121\u2013127. https:\/\/doi.org\/10.1002\/mds.26016","journal-title":"Mov Disord"},{"key":"8151_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fneur.2019.00351","volume":"10","author":"EM Gatto","year":"2019","unstructured":"Gatto EM, Aldinio V (2019) Impulse control disorders in Parkinson\u2019s disease. A brief and comprehensive review. Front Neurol 10:351. https:\/\/doi.org\/10.3389\/fneur.2019.00351","journal-title":"Front Neurol"},{"key":"8151_CR20","doi-asserted-by":"publisher","unstructured":"Cossu G, Rinaldi R, Colosimo C (2018) The rise and fall of impulse control behavior disorders. Parkinsonism Relat Disord 46(Suppl 1). https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.030.:S24-S29","DOI":"10.1016\/j.parkreldis.2017.07.030"},{"key":"8151_CR21","doi-asserted-by":"crossref","unstructured":"Lopez AM, Weintraub D, Claassen DO (2017) Impulse control disorders and related complications of Parkinson\u2019s disease therapy, Seminars in neurology. Thieme Medical, pp 186\u2013192","DOI":"10.1055\/s-0037-1601887"},{"key":"8151_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2016.12.058","volume":"374","author":"EM Maloney","year":"2017","unstructured":"Maloney EM, Djamshidian A, O\u2019Sullivan SS (2017) Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson\u2019s disease, atypical parkinsonian disorders and non-Parkinsonian populations. J Neurol Sci 374:47\u201352. https:\/\/doi.org\/10.1016\/j.jns.2016.12.058","journal-title":"J Neurol Sci"},{"key":"8151_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1590\/0004-282X20180052","volume":"76","author":"AP Vargas","year":"2018","unstructured":"Vargas AP, Cardoso FEC (2018) Impulse control and related disorders in Parkinson\u2019s disease. Arq Neuropsiquiatr 76:399\u2013410. https:\/\/doi.org\/10.1590\/0004-282X20180052","journal-title":"Arq Neuropsiquiatr"},{"key":"8151_CR24","first-page":"275","volume":"48","author":"MJ Carter","year":"2014","unstructured":"Carter MJ (2014) Diagnostic and statistical manual of mental disorders. Therapeutic Recreation J 48:275\u2013275","journal-title":"Therapeutic Recreation J"},{"key":"8151_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","volume":"368","author":"L Vela","year":"2016","unstructured":"Vela L, Martinez Castrillo JC, Garcia Ruiz P, Gasca-Salas C, Macias Macias Y, Perez Fernandez E et al (2016) The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: A cross-sectional multicenter study. J Neurol Sci 368:150\u2013154. https:\/\/doi.org\/10.1016\/j.jns.2016.07.003","journal-title":"J Neurol Sci"},{"key":"8151_CR26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10072-021-05237-8","volume":"42","author":"G Grassi","year":"2021","unstructured":"Grassi G, Albani G, Terenzi F, Razzolini L, Ramat S (2021) New Pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson\u2019s disease. Neurol Sci 42:2673\u20132682. https:\/\/doi.org\/10.1007\/s10072-021-05237-8","journal-title":"Neurol Sci"},{"key":"8151_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O\u2019Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405. https:\/\/doi.org\/10.1002\/mds.20045","journal-title":"Mov Disord"},{"key":"8151_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.baga.2017.06.002","volume":"9","author":"MB Callesen","year":"2017","unstructured":"Callesen MB, Damholdt MF (2017) Phenomenology and gender characteristics of hobbyism and punding in Parkinson\u2019s disease: A self-report study. Basal Ganglia 9:1\u20136","journal-title":"Basal Ganglia"},{"key":"8151_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.22505","volume":"24","author":"AH Evans","year":"2009","unstructured":"Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson\u2019s disease. Mov Disord 24:1561\u20131570. https:\/\/doi.org\/10.1002\/mds.22505","journal-title":"Mov Disord"},{"key":"8151_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/jnnp-2019-322453","volume":"91","author":"MJ Kelly","year":"2020","unstructured":"Kelly MJ, Baig F, Hu MT, Okai D (2020) Spectrum of impulse control behaviours in Parkinson\u2019s disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 91:703\u2013711. https:\/\/doi.org\/10.1136\/jnnp-2019-322453","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.2018.18040465","volume":"176","author":"D Weintraub","year":"2019","unstructured":"Weintraub D, Mamikonyan E (2019) Impulse control disorders in Parkinson\u2019s disease. Am J Psychiatry 176:5\u201311","journal-title":"Am J Psychiatry"},{"key":"8151_CR32","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1111\/ejn.13993","volume":"50","author":"L Angioletti","year":"2019","unstructured":"Angioletti L, Siri C, Meucci N, Pezzoli G, Balconi M (2019) Pathological gambling in Parkinson\u2019s disease: autonomic measures supporting impaired decision-making. Eur J Neurosci 50:2392\u20132400. https:\/\/doi.org\/10.1111\/ejn.13993","journal-title":"Eur J Neurosci"},{"key":"8151_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s40429-014-0027-6","volume":"1","author":"M Piquet-Pess\u00f4a","year":"2014","unstructured":"Piquet-Pess\u00f4a M, Ferreira GM, Melca IA, Fontenelle LF (2014) DSM-5 and the decision not to include sex, shopping or stealing as addictions. Curr Addict Rep 1:172\u2013176","journal-title":"Curr Addict Rep"},{"key":"8151_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.parkreldis.2010.02.004","volume":"16","author":"AB Bonfanti","year":"2010","unstructured":"Bonfanti AB, Gatto EM (2010) Kleptomania, an unusual impulsive control disorder in Parkinson\u2019s disease? Parkinsonism Relat Disord 16:358\u2013359. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.02.004","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/mdc3.13156","volume":"8","author":"D Amstutz","year":"2021","unstructured":"Amstutz D, Michelis JP, Debove I, Maradan-Gachet ME, Lachenmayer ML, Muellner J et al (2021) Reckless generosity, Parkinson\u2019s disease and dopamine: A case series and literature review. Mov Disord Clin Pract 8:469\u2013473. https:\/\/doi.org\/10.1002\/mdc3.13156","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589\u2013595. https:\/\/doi.org\/10.1001\/archneurol.2010.65","journal-title":"Arch Neurol"},{"key":"8151_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0269881106073109","volume":"21","author":"N Giladi","year":"2007","unstructured":"Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C (2007) New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson\u2019s disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 21:501\u2013506","journal-title":"J Psychopharmacol"},{"key":"8151_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","volume":"17","author":"A Hassan","year":"2011","unstructured":"Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA et al (2011) Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord 17:260\u2013264. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.01.009","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR39","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","volume":"91","author":"JC Corvol","year":"2018","unstructured":"Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P et al (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189\u2013e201. https:\/\/doi.org\/10.1212\/WNL.0000000000005816","journal-title":"Neurology"},{"key":"8151_CR40","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.27181","volume":"32","author":"R Biundo","year":"2017","unstructured":"Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC et al (2017) Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: the ALTHEA study. Mov Disord 32:1557\u20131565. https:\/\/doi.org\/10.1002\/mds.27181","journal-title":"Mov Disord"},{"key":"8151_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/mdc3.13211","volume":"8","author":"E Jaakkola","year":"2021","unstructured":"Jaakkola E, Joutsa J (2021) Screening instruments and prevalence of impulse control disorders. Mov Disord Clin Pract 8:816\u2013817. https:\/\/doi.org\/10.1002\/mdc3.13211","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mdc3.13128","volume":"8","author":"P Parra-D\u00edaz","year":"2021","unstructured":"Parra-D\u00edaz P, Chico\u2010Garc\u00eda JL, Beltr\u00e1n\u2010Corbellini \u00c1, Rodr\u00edguez\u2010Jorge F, Fern\u00e1ndez\u2010Escand\u00f3n CL, Alonso\u2010C\u00e1novas A et al (2021) Does the country make a difference in impulse control disorders? A systematic review. Mov Disorders Clin Pract 8:25\u201332","journal-title":"Mov Disorders Clin Pract"},{"key":"8151_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"V Voon","year":"2011","unstructured":"Voon V, Mehta AR, Hallett M (2011) Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr Opin Neurol 24:324\u2013330. https:\/\/doi.org\/10.1097\/WCO.0b013e3283489687","journal-title":"Curr Opin Neurol"},{"key":"8151_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.22164","volume":"68","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Sohr M, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010) Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 68:963\u2013968. https:\/\/doi.org\/10.1002\/ana.22164","journal-title":"Ann Neurol"},{"key":"8151_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1034\/j.1600-0447.2003.00162.x","volume":"108","author":"JE Grant","year":"2003","unstructured":"Grant JE, Kim SW (2003) Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr Scand 108:203\u2013207. https:\/\/doi.org\/10.1034\/j.1600-0447.2003.00162.x","journal-title":"Acta Psychiatr Scand"},{"key":"8151_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1212\/01.wnl.0000076478.45005.ec","volume":"61","author":"E Driver-Dunckley","year":"2003","unstructured":"Driver-Dunckley E, Samanta J, Stacy M (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson\u2019s disease. Neurology 61:422\u2013423. https:\/\/doi.org\/10.1212\/01.wnl.0000076478.45005.ec","journal-title":"Neurology"},{"key":"8151_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428. https:\/\/doi.org\/10.1136\/jnnp.68.4.423","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.euroneuro.2014.11.006","volume":"25","author":"FE Pontieri","year":"2015","unstructured":"Pontieri FE, Assogna F, Pellicano C, Cacciari C, Pannunzi S, Morrone A et al (2015) Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson\u2019s disease. Eur Neuropsychopharmacol 25:69\u201376. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"8151_CR49","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P et al (2014) Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85:840\u2013844. https:\/\/doi.org\/10.1136\/jnnp-2013-306787","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR50","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864\u2013870. https:\/\/doi.org\/10.1136\/jnnp-2015-311827","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR51","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13034","volume":"23","author":"A Rizos","year":"2016","unstructured":"Rizos A, Sauerbier A, Antonini A, Weintraub D, Martinez-Martin P, Kessel B et al (2016) A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists. Eur J Neurol 23:1255\u20131261. https:\/\/doi.org\/10.1111\/ene.13034","journal-title":"Eur J Neurol"},{"key":"8151_CR52","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/ene.13078","volume":"23","author":"A Antonini","year":"2016","unstructured":"Antonini A, Chaudhuri KR, Boroojerdi B, Asgharnejad M, Bauer L, Grieger F et al (2016) Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis. Eur J Neurol 23:1556\u20131565. https:\/\/doi.org\/10.1111\/ene.13078","journal-title":"Eur J Neurol"},{"key":"8151_CR53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mdc3.12416","volume":"4","author":"P Barbosa","year":"2017","unstructured":"Barbosa P, Lees AJ, Magee C, Djamshidian A, Warner TT (2017) A retrospective evaluation of the frequency of impulsive compulsive behaviors in Parkinson\u2019s disease patients treated with continuous waking day apomorphine pumps. Mov Disord Clin Pract 4:323\u2013328. https:\/\/doi.org\/10.1002\/mdc3.12416","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M et al (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol 16:238\u2013250. https:\/\/doi.org\/10.1016\/S1474-4422(17)30004-2","journal-title":"Lancet Neurol"},{"key":"8151_CR55","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4103\/0028-3886.237019","volume":"66","author":"S Bhattacharjee","year":"2018","unstructured":"Bhattacharjee S (2018) Impulse control disorders in Parkinson\u2019s disease: review of pathophysiology, epidemiology, clinical features, management, and future challenges. Neurol India 66:967\u2013975. https:\/\/doi.org\/10.4103\/0028-3886.237019","journal-title":"Neurol India"},{"key":"8151_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jnnp-2014-307904","volume":"86","author":"ML Fantini","year":"2015","unstructured":"Fantini ML, Macedo L, Zibetti M, Sarchioto M, Vidal T, Pereira B et al (2015) Increased risk of impulse control symptoms in Parkinson\u2019s disease with REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry 86:174\u2013179. https:\/\/doi.org\/10.1136\/jnnp-2014-307904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR57","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1176\/appi.ajp.158.11.1783","volume":"158","author":"FG Moeller","year":"2001","unstructured":"Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783\u20131793. https:\/\/doi.org\/10.1176\/appi.ajp.158.11.1783","journal-title":"Am J Psychiatry"},{"key":"8151_CR58","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/mdc3.13839","volume":"10","author":"F Giovannelli","year":"2023","unstructured":"Giovannelli F, Gavazzi G, Noferini C, Palumbo P, Viggiano MP, Cincotta M (2023) Impulsivity traits in Parkinson\u2019s disease: A systematic review and Meta-Analysis. Mov Disord Clin Pract 10:1448\u20131458. https:\/\/doi.org\/10.1002\/mdc3.13839","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","volume":"77","author":"G Santangelo","year":"2017","unstructured":"Santangelo G, Raimo S, Barone P (2017) The relationship between impulse control disorders and cognitive dysfunctions in Parkinson\u2019s disease: a meta-analysis. Neurosci Biobehavioral Reviews 77:129\u2013147","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"8151_CR60","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.pnpbp.2011.02.002","volume":"35","author":"P Solla","year":"2011","unstructured":"Solla P, Cannas A, Floris GL, Orofino G, Costantino E, Boi A et al (2011) Behavioral, neuropsychiatric and cognitive disorders in Parkinson\u2019s disease patients with and without motor complications. Prog Neuropsychopharmacol Biol Psychiatry 35:1009\u20131013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8151_CR61","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1093\/brain\/awz327","volume":"142","author":"PE Mosley","year":"2019","unstructured":"Mosley PE, Paliwal S, Robinson K, Coyne T, Silburn P, Tittgemeyer M et al (2019) The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson\u2019s disease. Brain 142:3917\u20133935. https:\/\/doi.org\/10.1093\/brain\/awz327","journal-title":"Brain"},{"key":"8151_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"key":"8151_CR63","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mds.27047","volume":"32","author":"DO Claassen","year":"2017","unstructured":"Claassen DO, Stark AJ, Spears CA, Petersen KJ, van Wouwe NC, Kessler RM et al (2017) Mesocorticolimbic hemodynamic response in Parkinson\u2019s disease patients with compulsive behaviors. Mov Disord 32:1574\u20131583. https:\/\/doi.org\/10.1002\/mds.27047","journal-title":"Mov Disord"},{"key":"8151_CR64","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T et al (2009) Increased striatal dopamine release in parkinsonian patients with pathological gambling: a [11\u00a0C] Raclopride PET study. Brain 132:1376\u20131385. https:\/\/doi.org\/10.1093\/brain\/awp054","journal-title":"Brain"},{"key":"8151_CR65","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","volume":"262","author":"K Wu","year":"2015","unstructured":"Wu K, Politis M, O\u2019Sullivan SS, Lawrence AD, Warsi S, Bose S et al (2015) Single versus multiple impulse control disorders in Parkinson\u2019s disease: an 11\u00a0C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol 262:1504\u20131514","journal-title":"J Neurol"},{"key":"8151_CR66","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK et al (2011) Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain 134:969\u2013978. https:\/\/doi.org\/10.1093\/brain\/awr003","journal-title":"Brain"},{"key":"8151_CR67","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mds.26135","volume":"30","author":"DE Payer","year":"2015","unstructured":"Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M et al (2015) [11\u00a0C]-(+)\u2010PHNO PET imaging of dopamine D2\/3 receptors in Parkinson\u2019s disease with impulse control disorders. Mov Disord 30:160\u2013166","journal-title":"Mov Disord"},{"key":"8151_CR68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G et al (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11\u00a0C] FLB-457 and PET study. Neurobiol Dis 48:519\u2013525. https:\/\/doi.org\/10.1016\/j.nbd.2012.06.021","journal-title":"Neurobiol Dis"},{"key":"8151_CR69","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3389\/fneur.2018.01018","volume":"9","author":"A Martini","year":"2018","unstructured":"Martini A, Dal Lago D, Edelstyn NMJ, Salgarello M, Lugoboni F, Tamburin S (2018) Dopaminergic neurotransmission in patients with Parkinson\u2019s disease and impulse control disorders: A systematic review and Meta-Analysis of PET and SPECT studies. Front Neurol 9:1018. https:\/\/doi.org\/10.3389\/fneur.2018.01018","journal-title":"Front Neurol"},{"key":"8151_CR70","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/npp.2009.124","volume":"34","author":"T van Eimeren","year":"2009","unstructured":"van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson\u2019s disease? Neuropsychopharmacology 34:2758\u20132766. https:\/\/doi.org\/10.1038\/npp.2009.124","journal-title":"Neuropsychopharmacology"},{"key":"8151_CR71","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/WNL.0000000000001619","volume":"84","author":"N Carriere","year":"2015","unstructured":"Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K (2015) Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology 84:2116\u20132123. https:\/\/doi.org\/10.1212\/WNL.0000000000001619","journal-title":"Neurology"},{"key":"8151_CR72","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881114548437","volume":"28","author":"A Djamshidian","year":"2014","unstructured":"Djamshidian A, O\u2019Sullivan SS, Lawrence AD, Foltynie T, Aviles-Olmos I, Magdalinou N et al (2014) Perceptual decision-making in patients with Parkinson\u2019s disease. J Psychopharmacol 28:1149\u20131154. https:\/\/doi.org\/10.1177\/0269881114548437","journal-title":"J Psychopharmacol"},{"key":"8151_CR73","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.25105","volume":"27","author":"A Djamshidian","year":"2012","unstructured":"Djamshidian A, O\u2019Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T et al (2012) Decision making, impulsivity, and addictions: do Parkinson\u2019s disease patients jump to conclusions? Mov Disord 27:1137\u20131145","journal-title":"Mov Disord"},{"key":"8151_CR74","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.neuropsychologia.2011.04.026","volume":"49","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, O\u2019Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB (2011) Novelty seeking behaviour in Parkinson\u2019s disease. Neuropsychologia 49:2483\u20132488. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2011.04.026","journal-title":"Neuropsychologia"},{"key":"8151_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-015-0316-2","volume":"15","author":"S Zainal Abidin","year":"2015","unstructured":"Zainal Abidin S, Tan EL, Chan S-C, Jaafar A, Lee AX, Abd Hamid MHN et al (2015) DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients. BMC Neurol 15:1\u201310","journal-title":"BMC Neurol"},{"key":"8151_CR76","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","volume":"87","author":"J Kraemmer","year":"2016","unstructured":"Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls MA, Cormier-Dequaire F et al (2016) Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 87:1106\u20131111. https:\/\/doi.org\/10.1136\/jnnp-2015-312848","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.parkreldis.2010.11.015","volume":"17","author":"K Papay","year":"2011","unstructured":"Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R et al (2011) Patient versus informant reporting of ICD symptoms in Parkinson\u2019s disease using the QUIP: validity and variability. Parkinsonism Relat Disord 17:153\u2013155. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.015","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR78","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans AH, Okai D, Weintraub D, Lim SY, O\u2019Sullivan SS, Voon V et al (2019) Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: critique and recommendations. Mov Disord 34:791\u2013798. https:\/\/doi.org\/10.1002\/mds.27689","journal-title":"Mov Disord"},{"key":"8151_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A (2012) Questionnaire for Impulsive-Compulsive disorders in Parkinson\u2019s Disease-Rating scale. Mov Disord 27:242\u2013247. https:\/\/doi.org\/10.1002\/mds.24023","journal-title":"Mov Disord"},{"key":"8151_CR80","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","volume":"165","author":"C Ardouin","year":"2009","unstructured":"Ardouin C, Chereau I, Llorca PM, Lhommee E, Durif F, Pollak P et al (2009) [Assessment of hyper- and hypodopaminergic behaviors in Parkinson\u2019s disease]. Rev Neurol (Paris) 165:845\u2013856. https:\/\/doi.org\/10.1016\/j.neurol.2009.06.003","journal-title":"Rev Neurol (Paris)"},{"key":"8151_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/JPD-160977","volume":"7","author":"AH Erga","year":"2017","unstructured":"Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF (2017) Impulsive and compulsive behaviors in Parkinson\u2019s disease: the Norwegian ParkWest study. J Parkinsons Dis 7:183\u2013191. https:\/\/doi.org\/10.3233\/JPD-160977","journal-title":"J Parkinsons Dis"},{"key":"8151_CR82","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/mdc3.12316","volume":"3","author":"D Okai","year":"2016","unstructured":"Okai D, Askey-Jones S, Mack J, Martin A, Chaudhuri KR, Samuel M et al (2016) Parkinson\u2019s Impulse-Control scale for the severity rating of Impulse-Control behaviors in Parkinson\u2019s disease: A semistructured clinical assessment tool. Mov Disord Clin Pract 3:494\u2013499. https:\/\/doi.org\/10.1002\/mdc3.12316","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR83","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/acn3.51569","volume":"9","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Posavi M, Fontanillas P, Tropea TF, Mamikonyan E, Suh E et al (2022) Genetic prediction of impulse control disorders in Parkinson\u2019s disease. Ann Clin Transl Neurol 9:936\u2013949. https:\/\/doi.org\/10.1002\/acn3.51569","journal-title":"Ann Clin Transl Neurol"},{"key":"8151_CR84","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mdc3.12455","volume":"4","author":"VK Hinson","year":"2017","unstructured":"Hinson VK, Delambo A, Elm J, Turner T (2017) A randomized clinical trial of Atomoxetine for mild cognitive impairment in Parkinson\u2019s disease. Mov Disord Clin Pract 4:416\u2013423. https:\/\/doi.org\/10.1002\/mdc3.12455","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR85","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/mds.22307","volume":"24","author":"L Marsh","year":"2009","unstructured":"Marsh L, Biglan K, Gerstenhaber M, Williams JR (2009) Atomoxetine for the treatment of executive dysfunction in Parkinson\u2019s disease: a pilot open-label study. Mov Disord 24:277\u2013282. https:\/\/doi.org\/10.1002\/mds.22307","journal-title":"Mov Disord"},{"key":"8151_CR86","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","volume":"75","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI et al (2010) Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 75:448\u2013455. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ebdd79","journal-title":"Neurology"},{"key":"8151_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S et al (2019) Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord 34:180\u2013198. https:\/\/doi.org\/10.1002\/mds.27602","journal-title":"Mov Disord"},{"key":"8151_CR88","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","volume":"80","author":"D Okai","year":"2013","unstructured":"Okai D, Askey-Jones S, Samuel M, O\u2019Sullivan SS, Chaudhuri KR, Martin A et al (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology 80:792\u2013799","journal-title":"Neurology"},{"key":"8151_CR89","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/mds.27340","volume":"33","author":"A Antonini","year":"2018","unstructured":"Antonini A, Moro E, Godeiro C, Reichmann H (2018) Medical and surgical management of advanced Parkinson\u2019s disease. Mov Disord 33:900\u2013908. https:\/\/doi.org\/10.1002\/mds.27340","journal-title":"Mov Disord"},{"key":"8151_CR90","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41582-019-0145-9","volume":"15","author":"P Limousin","year":"2019","unstructured":"Limousin P, Foltynie T (2019) Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol 15:234\u2013242. https:\/\/doi.org\/10.1038\/s41582-019-0145-9","journal-title":"Nat Rev Neurol"},{"key":"8151_CR91","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/mds.21098","volume":"21","author":"C Ardouin","year":"2006","unstructured":"Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H et al (2006) Pathological gambling in Parkinson\u2019s disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21:1941\u20131946. https:\/\/doi.org\/10.1002\/mds.21098","journal-title":"Mov Disord"},{"key":"8151_CR92","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1474-4422(18)30035-8","volume":"17","author":"E Lhommee","year":"2018","unstructured":"Lhommee E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L et al (2018) Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson\u2019s disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurol 17:223\u2013231. https:\/\/doi.org\/10.1016\/S1474-4422(18)30035-8","journal-title":"Lancet Neurol"},{"key":"8151_CR93","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/jnnp-2012-302387","volume":"84","author":"A Eusebio","year":"2013","unstructured":"Eusebio A, Witjas T, Cohen J, Fluchere F, Jouve E, Regis J et al (2013) Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 84:868\u2013874. https:\/\/doi.org\/10.1136\/jnnp-2012-302387","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000328817","volume":"9","author":"D Lule","year":"2012","unstructured":"Lule D, Heimrath J, Pinkhardt EH, Ludolph AC, Uttner I, Kassubek J (2012) Deep brain stimulation and behavioural changes: is comedication the most important factor? Neurodegener Dis 9:18\u201324. https:\/\/doi.org\/10.1159\/000328817","journal-title":"Neurodegener Dis"},{"key":"8151_CR95","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jnnp.2006.102061","volume":"78","author":"HM Smeding","year":"2007","unstructured":"Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B (2007) Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 78:517\u2013519. https:\/\/doi.org\/10.1136\/jnnp.2006.102061","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR96","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","volume":"16","author":"SY Lim","year":"2009","unstructured":"Lim SY, O\u2019Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD et al (2009) Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson\u2019s disease. J Clin Neurosci 16:1148\u20131152. https:\/\/doi.org\/10.1016\/j.jocn.2008.12.010","journal-title":"J Clin Neurosci"},{"key":"8151_CR97","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/mdc3.13738","volume":"10","author":"P Hernandez-Con","year":"2023","unstructured":"Hernandez-Con P, Lin I, Mamikonyan E, Deeb W, Feldman R, Althouse A et al (2023) Course of impulse control disorder symptoms in Parkinson\u2019s disease: deep brain stimulation versus medications. Mov Disord Clin Pract 10:903\u2013913. https:\/\/doi.org\/10.1002\/mdc3.13738","journal-title":"Mov Disord Clin Pract"},{"key":"8151_CR98","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1474-4422(13)70294-1","volume":"13","author":"A Castrioto","year":"2014","unstructured":"Castrioto A, Lhommee E, Moro E, Krack P (2014) Mood and behavioural effects of subthalamic stimulation in Parkinson\u2019s disease. Lancet Neurol 13:287\u2013305. https:\/\/doi.org\/10.1016\/S1474-4422(13)70294-1","journal-title":"Lancet Neurol"},{"key":"8151_CR99","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.26434","volume":"92","author":"S Prange","year":"2022","unstructured":"Prange S, Lin Z, Nourredine M, Danaila T, Laurencin C, Lagha-Boukbiza O et al (2022) Limbic stimulation drives mania in STN-DBS in Parkinson disease: A prospective study. Ann Neurol 92:411\u2013417. https:\/\/doi.org\/10.1002\/ana.26434","journal-title":"Ann Neurol"},{"key":"8151_CR100","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1590\/0004-282X20150217","volume":"74","author":"HA Teive","year":"2016","unstructured":"Teive HA, Moro A, Moscovich M, Munhoz RP (2016) Increased sexual arousal in patients with movement disorders. Arq Neuropsiquiatr 74:303\u2013306. https:\/\/doi.org\/10.1590\/0004-282X20150217","journal-title":"Arq Neuropsiquiatr"},{"key":"8151_CR101","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/jnnp-2017-316373","volume":"89","author":"M Abbes","year":"2018","unstructured":"Abbes M, Lhommee E, Thobois S, Klinger H, Schmitt E, Bichon A et al (2018) Subthalamic stimulation and neuropsychiatric symptoms in Parkinson\u2019s disease: results from a long-term follow-up cohort study. J Neurol Neurosurg Psychiatry 89:836\u2013843. https:\/\/doi.org\/10.1136\/jnnp-2017-316373","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8151_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.010","volume":"56","author":"A Kim","year":"2018","unstructured":"Kim A, Kim YE, Kim HJ, Yun JY, Yang HJ, Lee WW et al (2018) A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 56:3\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.010","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR103","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L et al (2013) Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med 368:610\u2013622. https:\/\/doi.org\/10.1056\/NEJMoa1205158","journal-title":"N Engl J Med"},{"key":"8151_CR104","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/09602011.2011.622435","volume":"21","author":"C Miniussi","year":"2011","unstructured":"Miniussi C, Vallar G (2011) Brain stimulation and behavioural cognitive rehabilitation: a new tool for neurorehabilitation? Neuropsychol Rehabil 21:553\u2013559. https:\/\/doi.org\/10.1080\/09602011.2011.622435","journal-title":"Neuropsychol Rehabil"},{"key":"8151_CR105","doi-asserted-by":"publisher","first-page":"113733","DOI":"10.1016\/j.bbr.2022.113733","volume":"422","author":"N Kamble","year":"2022","unstructured":"Kamble N, Bhattacharya A, Hegde S, Vidya N, Gothwal M, Yadav R et al (2022) Cortical excitability changes as a marker of cognitive impairment in Parkinson\u2019s disease. Behav Brain Res 422:113733\u2013113733","journal-title":"Behav Brain Res"},{"key":"8151_CR106","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/pcn.13523","volume":"77","author":"D Mata-Marin","year":"2023","unstructured":"Mata-Marin D, Pineda-Pardo JA, Michiels M, Pagge C, Ammann C, Martinez-Fernandez R et al (2023) A circuit-based approach to modulate hypersexuality in Parkinson\u2019s disease. Psychiatry Clin Neurosci 77:223\u2013232. https:\/\/doi.org\/10.1111\/pcn.13523","journal-title":"Psychiatry Clin Neurosci"},{"key":"8151_CR107","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00702-013-1100-3","volume":"121","author":"R Nardone","year":"2014","unstructured":"Nardone R, De Blasi P, Holler Y, Christova M, Tezzon F, Trinka E et al (2014) Repetitive transcranial magnetic stimulation transiently reduces punding in Parkinson\u2019s disease: a preliminary study. J Neural Transm (Vienna) 121:267\u2013274. https:\/\/doi.org\/10.1007\/s00702-013-1100-3","journal-title":"J Neural Transm (Vienna)"},{"key":"8151_CR108","unstructured":"Yawen C, Jiang H, Yixin WEI, Saiqing YE, Jiang J, Margaret MAK et al (2024) Effects of Non-invasive brain stimulation over the supplementary motor area on motor function in Parkinson\u2019s disease: A systematic review and Meta-Analysis. Brain Stimulation"},{"key":"8151_CR109","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.009","volume":"68","author":"TM Mi","year":"2019","unstructured":"Mi TM, Garg S, Ba F, Liu AP, Wu T, Gao LL et al (2019) High-frequency rTMS over the supplementary motor area improves freezing of gait in Parkinson\u2019s disease: a randomized controlled trial. Parkinsonism Relat Disord 68:85\u201390. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.009","journal-title":"Parkinsonism Relat Disord"},{"key":"8151_CR110","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3988\/jcn.2018.14.3.320","volume":"14","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Paeng SH, Kang SY (2018) Stimulation in supplementary motor area versus motor cortex for freezing of gait in Parkinson\u2019s disease. J Clin Neurol 14:320\u2013326. https:\/\/doi.org\/10.3988\/jcn.2018.14.3.320","journal-title":"J Clin Neurol"},{"key":"8151_CR111","doi-asserted-by":"publisher","first-page":"134837","DOI":"10.1016\/j.neulet.2020.134837","volume":"724","author":"L Hanoglu","year":"2020","unstructured":"Hanoglu L, Saricaoglu M, Toprak G, Yilmaz NH, Yulug B (2020) Preliminary findings on the role of high-frequency (5Hz) rTMS stimulation on M1 and pre-SMA regions in Parkinson\u2019s disease. Neurosci Lett 724:134837. https:\/\/doi.org\/10.1016\/j.neulet.2020.134837","journal-title":"Neurosci Lett"},{"key":"8151_CR112","doi-asserted-by":"publisher","first-page":"14840","DOI":"10.1038\/s41598-017-13260-z","volume":"7","author":"AM Goodwill","year":"2017","unstructured":"Goodwill AM, Lum JAG, Hendy AM, Muthalib M, Johnson L, Albein-Urios N et al (2017) Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson\u2019s disease: a systematic review and meta-analysis. Sci Rep 7:14840. https:\/\/doi.org\/10.1038\/s41598-017-13260-z","journal-title":"Sci Rep"},{"key":"8151_CR113","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12311-015-0737-x","volume":"15","author":"R Ferrucci","year":"2016","unstructured":"Ferrucci R, Cortese F, Bianchi M, Pittera D, Turrone R, Bocci T et al (2016) Cerebellar and motor cortical transcranial stimulation decrease Levodopa-Induced dyskinesias in Parkinson\u2019s disease. Cerebellum 15:43\u201347. https:\/\/doi.org\/10.1007\/s12311-015-0737-x","journal-title":"Cerebellum"},{"key":"8151_CR114","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12883-020-01953-4","volume":"20","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Guo Z, McClure MA, He L, Mu Q (2020) Effect of rTMS on Parkinson\u2019s cognitive function: a systematic review and meta-analysis. BMC Neurol 20:377. https:\/\/doi.org\/10.1186\/s12883-020-01953-4","journal-title":"BMC Neurol"},{"key":"8151_CR115","doi-asserted-by":"publisher","first-page":"597955","DOI":"10.3389\/fneur.2020.597955","volume":"11","author":"DMA Suarez-Garcia","year":"2020","unstructured":"Suarez-Garcia DMA, Grisales-Cardenas JS, Zimerman M, Cardona JF (2020) Transcranial direct current stimulation to enhance cognitive impairment in Parkinson\u2019s disease: A systematic review and Meta-Analysis. Front Neurol 11:597955. https:\/\/doi.org\/10.3389\/fneur.2020.597955","journal-title":"Front Neurol"},{"key":"8151_CR116","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/15459683221095034","volume":"36","author":"R Li","year":"2022","unstructured":"Li R, He Y, Qin W, Zhang Z, Su J, Guan Q et al (2022) Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson\u2019s disease: A Meta-Analysis. Neurorehabil Neural Repair 36:395\u2013404. https:\/\/doi.org\/10.1177\/15459683221095034","journal-title":"Neurorehabil Neural Repair"},{"key":"8151_CR117","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.eclinm.2022.101589","volume":"52","author":"W Zhang","year":"2022","unstructured":"Zhang W, Deng B, Xie F, Zhou H, Guo JF, Jiang H et al (2022) Efficacy of repetitive transcranial magnetic stimulation in Parkinson\u2019s disease: A systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine 52:101589. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101589","journal-title":"EClinicalMedicine"},{"key":"8151_CR118","doi-asserted-by":"crossref","unstructured":"Giustiniani A, Maistrello L, Mologni V, Danesin L, Burgio F (2024) TMS and tDCS as potential tools for the treatment of cognitive deficits in Parkinson\u2019s disease: A meta-analysis. Neurol Sci 1\u201314","DOI":"10.1007\/s10072-024-07778-0"},{"key":"8151_CR119","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3389\/fpsyt.2018.00769","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Guo Z, Xing G, Peng H, Cai M, Chen H et al (2018) Antidepressant effects of repetitive transcranial magnetic stimulation over prefrontal cortex of Parkinson\u2019s disease patients with depression: A Meta-Analysis. Front Psychiatry 9:769. https:\/\/doi.org\/10.3389\/fpsyt.2018.00769","journal-title":"Front Psychiatry"},{"key":"8151_CR120","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fpsyt.2020.00158","volume":"11","author":"G Madeo","year":"2020","unstructured":"Madeo G, Terraneo A, Cardullo S, Gomez Perez LJ, Cellini N, Sarlo M et al (2020) Long-Term outcome of repetitive transcranial magnetic stimulation in a large cohort of patients with Cocaine-Use disorder: an observational study. Front Psychiatry 11:158. https:\/\/doi.org\/10.3389\/fpsyt.2020.00158","journal-title":"Front Psychiatry"},{"key":"8151_CR121","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3928\/00485713-20150602-07","volume":"45","author":"S Pallanti","year":"2015","unstructured":"Pallanti S, Marras A, Grassi G (2015) Outcomes with neuromodulation in obsessive-compulsive disorder. Psychiatric Annals 45:316\u2013320","journal-title":"Psychiatric Annals"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08151-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:17:07Z","timestamp":1757157427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08151-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8151"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08151-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as no participants were recruited during this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable, as no participants were recruited during this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participant"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}